Reference number : 236-2017-2018-Q4-00290, amendment number : , agreement type : G, recipient legal name : Coles, John G, recipient country : CA, recipient province : ON, recipient city : Toronto, recipient postal code : M5G 1X8, program name english : nan, program name french : nan, program purpose english : nan, program purpose french : nan, agreement title english : nan, agreement title french : nan, agreement number : nan, agreement value : 512550.0, agreement start date : 2018-04-01, agreement end date : 2021-03-31, description english : Integrin Linked Kinase as a Novel Therapeutic Target for Heart Failure, description french : Integrin Linked Kinase as a Novel Therapeutic Target for Heart Failure, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year.
(2018-19 to 2020-21), additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier.
(2018-19 à 2020-21), owner organization : cihr-irsc, owner organization title : Canadian Institutes of Health Research | Instituts de recherche en santé du Canada